Israel Gomy

Israel Gomy

Harvard University

H-index: 11

North America-United States

About Israel Gomy

Israel Gomy, With an exceptional h-index of 11 and a recent h-index of 7 (since 2020), a distinguished researcher at Harvard University, specializes in the field of Cancer genetics.

His recent articles reflect a diverse array of research interests and contributions to the field:

Safety and efficacy of zolbetuximab for CLDN18. 2-positive gastric or gastroesophageal junction adenocarcinoma: A systematic review and meta-analysis of randomized controlled …

Identification and Management of Pathogenic Variants in BRCA1, BRCA2, and PALB2 in a Tumor-Only Genomic Testing Program

Suscetibilidade ao Câncer Colorretal em Brasileiros por Genotipagem de Polimorfismos de Nucleotídeo Único Conhecidos

Newborn Screening for the Detection of the TP53 R337H Variant and Surveillance for Early Diagnosis of Pediatric Adrenocortical Tumors: Lessons Learned and …

Germline testing data validate inferences of mutational status for variants detected from tumor-only sequencing

Identification and management of pathogenic mutations in BRCA1, BRCA2, and PALB2 in a tumor-only genomic testing program.

Clinical and molecular evaluation of 13 Brazilian patients with Gomez‐López‐Hernández syndrome

One step forward, two steps backward

Israel Gomy Information

University

Position

Dana-Farber Cancer Institute

Citations(all)

492

Citations(since 2020)

213

Cited By

352

hIndex(all)

11

hIndex(since 2020)

7

i10Index(all)

15

i10Index(since 2020)

5

Email

University Profile Page

Google Scholar

Israel Gomy Skills & Research Interests

Cancer genetics

Top articles of Israel Gomy

Title

Journal

Author(s)

Publication Date

Safety and efficacy of zolbetuximab for CLDN18. 2-positive gastric or gastroesophageal junction adenocarcinoma: A systematic review and meta-analysis of randomized controlled …

Davi Said Gonçalves Celso

Pedro Cotta Abrahão Reis

Lorena Escalante-Romero

Maria Inez Dacoregio

Israel Gomy

...

2024/1/20

Identification and Management of Pathogenic Variants in BRCA1, BRCA2, and PALB2 in a Tumor-Only Genomic Testing Program

Clinical Cancer Research

Brittany L Bychkovsky

Tianyu Li

Jilliane Sotelo

Nabihah Tayob

Joanna Mercado

...

2022/6/1

Suscetibilidade ao Câncer Colorretal em Brasileiros por Genotipagem de Polimorfismos de Nucleotídeo Único Conhecidos

Israel Gomy

2022/5/30

Newborn Screening for the Detection of the TP53 R337H Variant and Surveillance for Early Diagnosis of Pediatric Adrenocortical Tumors: Lessons Learned and …

Cancers

Karina CF Tosin

Edith F Legal

Mara AD Pianovski

Humberto C Ibañez

Gislaine Custódio

...

2021/12/3

Germline testing data validate inferences of mutational status for variants detected from tumor-only sequencing

JCO Precision Oncology

Nahed Jalloul

Israel Gomy

Samantha Stokes

Alexander Gusev

Bruce E Johnson

...

2021/11

Identification and management of pathogenic mutations in BRCA1, BRCA2, and PALB2 in a tumor-only genomic testing program.

Brittany L Bychkovsky

Tianyu Li

Jilliane Sotelo

Nabihah Tayob

Joanna Mercado

...

2021/5/20

Clinical and molecular evaluation of 13 Brazilian patients with Gomez‐López‐Hernández syndrome

American Journal of Medical Genetics Part A

Eduardo Perrone

Ana Beatriz Alvarez Perez

Vânia D'Almeida

Claudia Berlim de Mello

Marcela Amaral Avelino Jacobina

...

2021/4

One step forward, two steps backward

Genetics in Medicine

Israel Gomy

Judy E Garber

2020/2

See List of Professors in Israel Gomy University(Harvard University)